Alector Inc. (ALEC) Fundamentals

Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline product inlcude AL001, AL002, AL003, and AL101.
SHARE INFORMATION
Market CapUS$ 729,416,529
Shares Outstanding82,326,922
Float61,648,231
Percent Float74.88%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 207,085,000
Latest Fiscal EPSUS$ -0.54
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions396
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months8,303,917
Institutional Holdings Percent137.5%
Institutional Sold Previous 3 Months2,703,867
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months868,000
Insider Holdings Percent7.0
Insider Sold Previous 3 Months287
Insider Shares Owned5,748,811
TRADING INFO
52 Week HighUS$ 43.32
52 Week LowUS$ 7.50
52 Week High ChangeUS$ -49.72
21 Day Moving AverageUS$ 9.0857
21 Day Extended Moving AverageUS$ 9.3827
50 Day Moving AverageUS$ 11.4859
50 Day Extended Moving AverageUS$ 11.1076
200 Day Moving AverageUS$ 18.6911
200 Day Extended Moving AverageUS$ 16.464
10 Day Average Volume770,391
20 Day Average Volume787,104
30 Day Average Volume737,457
50 Day Average Volume705,873
Alpha-0.016751
Beta1.3622
Standard Deviation0.196263
R20.133146
7 Day Price ChangeUS$ 0.09
7 Day Percent Change1.03%
21 Day Price ChangeUS$ -1.34
21 Day Percent Change-13.14%
30 Day Price ChangeUS$ -1.76
30 Day Percent Change-16.57%
Month to Date Price ChangeUS$ -0.74
Month to Date Percent Change-7.71%
Quarter to Date Price ChangeUS$ -5.39
Quarter to Date Percent Change-37.82%
180 Day Price ChangeUS$ -12.42
180 Day Percent Change-58.36%
200 Day Price ChangeUS$ -16.24
200 Day Percent Change-64.7%
Year to Date Price ChangeUS$ -11.79
Year to Date Percent Change-57.09%

Alector Inc. (ALEC) Key Ratios

PROFITABILITY
EBIT Margin-12.7%
EBITDA Margin-8.9%
Pre-Tax Profit Margin-570.8%
Profit Margin Count-12.98%
Gross Margin0.0%
Profit Margin TOT-12.98%
INCOME STATEMENTS
RevenueUS$ 227,449,000
Revenue Per ShareUS$ 2.7628
Revenue (3 Years)US$ 93.64
Revenue (5 Years)US$ 137.20
FINANCIAL STRENGTH
Price to Tangible Book2.70
Total Debt To Equity0.20
Int Coverage0.00
Current Ratio6.20
Leverage Ratio2.80
Quick Ratio6.20
Long Term Debt To Capital0.13
VALUATION MEASURES
PE Ratio-20.90
Enterprise ValueUS$ -98,311,356
Price to Sales3.2069
Price to Free Cash1.50
PE High Last 5 Years0.00
Price To Book2.70
Price To Cash Flow1.50
PE Low Last 5 Years0.00
Price to Tangible Book2.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover34.60
Invoice Turnover0.00
Assets Turnover0.30
Return Assets-4.20
Return on Equity-11.92
Return on Capital-9.71

Alector Inc. (ALEC) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOArnon Rosenthal
Emplyoees208
Last AuditUQ
CIK0001653087
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address131 Oyster Point Boulevard
Suite 600
South San Francisco, CA 94080
Websitehttps://www.alector.com
Facsimile-
Telephone+1 415 231-5660
Email-
Your Recent History
NASDAQ
ALEC
Alector
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20220526 23:40:15